Michael Gelband’s SI-BONE Inc SIBN Stock Holding History

Michael Gelband’s Portfolio SIBN Stock Details SIBN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,000	Closed	-$919K	–	2554
2020 Q4	$919K	Buy	+30,000	New	+$730K	0.01%	897

Other funds holding SIBN

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Michael Gelband's SIBN Position: Q1 2026 in Review

Michael Gelband sold out of SI-BONE Inc (SIBN) in Q1 2026, closing a stake of 170,431 shares — an estimated $3.36M sold.

Michael Gelband first reported a position in SIBN in Q3 2020 and held it in 8 quarters. The position peaked at $3.36M in Q4 2025. 180 funds tracked by Wall St. Rank hold SIBN as of Q1 2026.

Michael Gelband reported no remaining SI-BONE Inc position as of Q1 2026 after selling out during the quarter.
Michael Gelband sold 170,431 SI-BONE Inc shares in Q1 2026, an estimated $3.36M.
Michael Gelband first reported a position in SI-BONE Inc in Q3 2020 and held it in 8 quarters.
Michael Gelband's SI-BONE Inc position peaked at $3.36M in Q4 2025.
180 funds tracked by Wall St. Rank held SI-BONE Inc as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.